Cell, tissue or DNA sample: Cell line or tissue used as the source of experimental material.
cellTierDescriptionLineageTissueKaryotypeSexDocumentsVendor IDTerm IDLabel
A549 2 epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis endoderm epithelium cancer M Myers
Crawford
Stam  		 ATCC CCL-185 BTO:0000018 A549
CD20+ 2 B cells from donors RO01778 and RO01794, newly promoted to tier 2: not in 2011 analysis mesoderm blood normal F Stam   Dr. Heimfeld Lab at FHCRC CD20+ BTO:0000776 B-cells CD20+
CD20+_RO01778 2 B cells, caucasian, draw number 1, newly promoted to tier 2: not in 2011 analysis mesoderm blood normal F Stam   Rajinder Kaul, UW CD20+_RO01778 BTO:0000776 B-cells CD20+ (RO01778)
CD20+_RO01794 2 B cells, African American, draw number 1, newly promoted to tier 2: not in 2011 analysis mesoderm blood normal F Stam   Rajinder Kaul, UW CD20+_RO01794 BTO:0000776 B cells CD20+ RO01794
H1-neurons 2 neurons derived from H1 embryonic stem cells, newly promoted to tier 2: not in 2011 analysis ectoderm neurons normal M Cellular Dynamics International Batch 1
Cellular Dynamics International Batch 2  		 CDI TBD BTO:0000938 H1-neurons
HeLa-S3 2 cervical carcinoma ectoderm cervix cancer F ENCODE
Crawford  		 ATCC CCL-2.2 BTO:0000568 HeLa-S3
HepG2 2 hepatocellular carcinoma endoderm liver cancer M ENCODE   ATCC HB-8065 BTO:0000599 HepG2
HUVEC 2 umbilical vein endothelial cells mesoderm blood vessel normal U ENCODE   Lonza CC-2517 BTO:0001949 HUVEC
IMR90 2 fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis endoderm lung normal F Stam   ATCC CCL-186 BTO:0001229 IMR90
LHCN-M2 2 skeletal myoblasts derived from satellite cells from the pectoralis major muscle of a 41 year old caucasian heart transplant donor, immortalized with lox-hygro-hTERT ("LH"), and Cdk4-neo ("CN"), Zhu et al. (2007) in Aging Cell, vol. 6, pp 515-523, newly promoted to tier 2: not in 2011 analysis. mesoderm skeletal muscle myoblast   M Wold   Dr. Woodring Wright Missing BTO:0005046 LHCN-M2
MCF-7 2 mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis ectoderm breast cancer F Crawford
Farnham
Stam  		 ATCC HTB-22 BTO:0000093 MCF-7
Monocytes-CD14+ 2 Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, from donor RO 01746 (draw 1 ID is RO 01746, draw 2 ID is RO 01826), newly promoted to tier 2: not in 2011 analysis mesoderm monocytes normal F Stam   S. Heimfeld Laboratory, FHCRC Monocytes-CD14+ BTO:0000876 Monocytes CD14+
Monocytes-CD14+_RO01746 2 Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, from donor RO 01746 (draw 1 ID is RO 01746, draw 2 ID is RO 01826), Monocytes-CD14+_RO01746 and Monocytes-CD14+_RO01826 are being used as replicates, newly promoted to tier 2: not in 2011 analysis mesoderm monocytes normal F Stam   S. Heimfeld Laboratory, FHCRC Monocytes-CD14+_RO01746 BTO:0000876 Monocytes CD14+ RO01746
Monocytes-CD14+_RO01826 2 Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, Monocytes-CD14+_RO01826 is a second draw being used as a replicate for Monocytes-CD14+_RO01746, newly promoted to tier 2: not in 2011 analysis mesoderm monocytes normal F Stam   S. Heimfeld Laboratory, FHCRC Monocytes-CD14+_RO01826 BTO:0000876 Monocytes CD14+ RO01826
SK-N-SH 2 neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. ectoderm brain cancer F Myers   ATCC HTB-11 BTO:0001620 SK-N-SH

Total = 15